dr. leal on the rationale for the ecog-acrin ea5161 trial in es-sclc
Published 3 years ago • 233 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
11:56
additional advances in non–small cell lung cancer research and clinical trials with ticiana leal, md
-
7:13
i/o chemotherapy in treatment-naïve es-sclc
-
51:59
facilitating progress in the treatment of sclc
-
1:10:02
watch dr goldman, leal, and owonikoko, discuss the latest sclc updates - https://bit.ly/3jkp0l5
-
2:35
atezo maintenance therapy improves survival in the impower133 trial of es-sclc
-
1:31:45
making the most of treatment advances in sclc
-
5:43
novel immunotherapy combinations for sclc
-
5:39
researcher comment: the ecog-acrin e2108 trial | seema khan
-
0:50
targeted option for non-small cell lung cancer #2023 #oncology #lungcancer
-
1:24
dr. halmos on recent advancements in non–small cell lung cancer
-
8:11
first-line immunotherapy: impower133 regimen
-
1:08:56
toward better outcomes in sclc: immunotherapy has changed the game, but where do we go next?
-
0:51
dr. casulo on predicting outcomes in follicular lymphoma
-
3:51
ecog 2511 small cell lung cancer clinical trial
-
18:31
case study: sequencing therapy in es-sclc in special patient populations
-
1:33
dr. chaft on the emergence of immunotherapy in stage iv lung cancer
-
1:30
dr. feliciano on nivolumab in small cell lung cancer
-
0:31
is it non small cell or small cell?
-
1:36
ensartinib for advanced alk rearranged non-small cell lung cancer